Adage Capital Partners
AGIO icon

Adage Capital Partners’s Agios Pharmaceuticals AGIO Stock Holding History

Adage Capital Partners’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-800,000
Closed -$32.1M – 913
2025
Q3 		$32.1M Buy
800,000
+9,000
+1% +$339K 0.05% 344
2025
Q2 		$26.3M Buy
791,000
+48,000
+6% +$1.45M 0.04% 377
2025
Q1 		$21.8M Buy
743,000
+440,000
+145% +$14.6M 0.04% 393
2024
Q4 		$9.96M Buy
+303,000
New +$14.2M 0.02% 610
2013
Q4 		– Sell
-32,500
Closed -$909K – 676
2013
Q3 		$909K Buy
+32,500
New +$897K ﹤0.01% 662

Other funds holding AGIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Adage Capital Partners's AGIO Position: Q4 2025 in Review

Adage Capital Partners sold out of Agios Pharmaceuticals (AGIO) in Q4 2025, closing a stake of 800,000 shares — an estimated $32.1M sold.

Adage Capital Partners first reported a position in AGIO in Q3 2013 and held it in 5 quarters. The position peaked at $32.1M in Q3 2025. 238 funds tracked by Wall St. Rank hold AGIO as of Q4 2025.

  • Adage Capital Partners reported no remaining Agios Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Adage Capital Partners sold 800,000 Agios Pharmaceuticals shares in Q4 2025, an estimated $32.1M.
  • Adage Capital Partners first reported a position in Agios Pharmaceuticals in Q3 2013 and held it in 5 quarters.
  • Adage Capital Partners's Agios Pharmaceuticals position peaked at $32.1M in Q3 2025.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2025.

Based on Adage Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.